CETUXIMAB COMBINED WITH INFUSIONAL 5-FLUOROURACIL/FOLINIC ACID AND OXALIPLATIN IN METASTATIC COLORECTAL CANCER: POOLED ANALYSIS OF COIN AND OPUS STUDY DATA by Taieb, J, Maughan, T, Bokemeyer, C, Van Cutsem, E, Brodowicz, T, Folprecht, G, Esser, R, Schlichting, M, Tabernero, J

Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials. by Giatromanolaki, A, Koukourakis, M, Sivridis, E, Gatter, K, Trarbach, T, Folprecht, G, Shi, M, Lebwohl, D, Jalava, T, Laurent, D, Meinhardt, G, Harris, A

Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584 (vatalanib) antiangiogenic therapy. by Koukourakis, M, Giatromanolaki, A, Sivridis, E, Gatter, K, Trarbach, T, Folprecht, G, Shi, M, Lebwohl, D, Jalava, T, Laurent, D, Meinhardt, G, Harris, A

Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized control... by Folprecht, G, Seymour, M, Saltz, L, Douillard, J, Hecker, H, Stephens, R, Maughan, T, Van Cutsem, E, Rougier, P, Mitry, E, Schubert, U, Köhne, C